U.S. markets closed

Jaguar Health, Inc. (JAGX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.3100+0.0700 (+5.65%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 5/8/2021
Current
12/31/20209/30/20206/30/20203/31/2020
Market Cap (intraday) 5
179.89M92.93M14.16M15.73M8.80M
Enterprise Value 3
188.01M106.71M21.53M23.67M23.26M
Trailing P/E
N/A0.240.010.07N/A
Forward P/E 1
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
5.392.230.640.830.18
Price/Book (mrq)
10.4641.8022.543.250.80
Enterprise Value/Revenue 3
20.0341.437.777.4726.76
Enterprise Value/EBITDA 7
-6.54-15.68-3.23-2.90-3.27

Trading Information

Stock Price History

Beta (5Y Monthly) 1.37
52-Week Change 3142.59%
S&P500 52-Week Change 344.45%
52 Week High 34.4700
52 Week Low 30.1850
50-Day Moving Average 31.6441
200-Day Moving Average 31.5535

Share Statistics

Avg Vol (3 month) 311.19M
Avg Vol (10 day) 36.34M
Shares Outstanding 5137.32M
Implied Shares Outstanding 6137.32M
Float 127.43M
% Held by Insiders 19.90%
% Held by Institutions 17.68%
Shares Short (Apr 14, 2021) 45.41M
Short Ratio (Apr 14, 2021) 40.86
Short % of Float (Apr 14, 2021) 44.24%
Short % of Shares Outstanding (Apr 14, 2021) 44.23%
Shares Short (prior month Mar 14, 2021) 43.94M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jun 06, 2019
Ex-Dividend Date 4N/A
Last Split Factor 21:70
Last Split Date 3Jun 06, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Dec 30, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-227.00%

Management Effectiveness

Return on Assets (ttm)-33.60%
Return on Equity (ttm)-179.03%

Income Statement

Revenue (ttm)9.38M
Revenue Per Share (ttm)0.24
Quarterly Revenue Growth (yoy)70.90%
Gross Profit (ttm)6.11M
EBITDA -19.58M
Net Income Avi to Common (ttm)-38.65M
Diluted EPS (ttm)-1.0000
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)8.09M
Total Cash Per Share (mrq)0.06
Total Debt (mrq)16.21M
Total Debt/Equity (mrq)94.23
Current Ratio (mrq)1.35
Book Value Per Share (mrq)0.15

Cash Flow Statement

Operating Cash Flow (ttm)-15.28M
Levered Free Cash Flow (ttm)-8.83M